Niagen Bioscience, Inc. SEC filings NAGE

Niagen Bioscience, Inc. has 981 filings in SEC EDGAR's recent list, going back to Jan 18, 2007. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Niagen Bioscience, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2026 Nov 4, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 4, 2026 Aug 4, 2026
424B5 Prospectus supplement Jul 10, 2026 —
EFFECT Filing Jul 9, 2026 —
8-K Current report
Shareholder vote results
Jun 29, 2026 Jun 24, 2026
S-3 Shelf registration Jun 29, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2026 May 6, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
ARS Annual report to shareholders Apr 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 29, 2026 —
DEF 14A Proxy statement Apr 29, 2026 Jun 24, 2026
8-K Current report
Other events
Mar 19, 2026 Mar 19, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Mar 4, 2026 Mar 4, 2026
10-K Annual report Mar 4, 2026 Dec 31, 2025
8-K Current report
Regulation FD disclosure, Other events
Feb 26, 2026 Feb 24, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Dec 22, 2025 Dec 18, 2025
8-K Current report
Other events
Nov 6, 2025 Nov 6, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2025 Nov 4, 2025
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Regulation FD disclosure
Oct 6, 2025 Oct 6, 2025
S-8 Employee stock plan registration Aug 8, 2025 —
S-8 Employee stock plan registration Aug 8, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2025 Aug 6, 2025
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Material agreement
Jul 29, 2025 Jul 25, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 27, 2025 Jun 24, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 7, 2025 May 7, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Dec 31, 2024
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Mar 19, 2025 Mar 17, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 4, 2025 Mar 4, 2025
10-K Annual report Mar 4, 2025 Dec 31, 2024
8-K Current report
Officer or director change
Feb 27, 2025 Feb 25, 2025
8-K Current report
Auditor change
Dec 16, 2024 Dec 13, 2024
8-K Current report
Other events
Dec 4, 2024 Dec 4, 2024
424B3 Prospectus Nov 21, 2024 —
8-K Current report
Material agreement
Nov 21, 2024 Nov 20, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Oct 31, 2024 Oct 31, 2024
10-Q Quarterly report Oct 31, 2024 Sep 30, 2024
8-K Current report
Auditor change
Oct 11, 2024 Oct 8, 2024
8-K Current report
Officer or director change
Sep 20, 2024 Sep 19, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2024 Aug 7, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Jul 16, 2024 Jul 16, 2024
8-K Current report
Officer or director change
Jun 25, 2024 Jun 19, 2024
8-K Current report
Shareholder vote results
Jun 24, 2024 Jun 20, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2024 May 8, 2024
10-Q Quarterly report May 8, 2024 Mar 31, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Apr 25, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 6, 2024 Mar 6, 2024
10-K Annual report Mar 6, 2024 Dec 31, 2023
8-K Current report
Material agreement, New debt
Dec 13, 2023 Dec 8, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 8, 2023 Nov 8, 2023
10-Q Quarterly report Nov 8, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2023 Aug 9, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
424B5 Prospectus supplement Jul 6, 2023 —
EFFECT Filing Jul 5, 2023 —
CORRESP Letter to the SEC Jun 30, 2023 —
UPLOAD Letter from the SEC Jun 27, 2023 —
S-8 Employee stock plan registration Jun 22, 2023 —
S-3 Shelf registration Jun 22, 2023 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 20, 2023 Jun 15, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 10, 2023 May 10, 2023
10-Q Quarterly report May 10, 2023 Mar 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 —
PRE 14A Preliminary proxy statement Apr 19, 2023 —
8-K Current report
Bylaw or fiscal year change
Mar 17, 2023 Mar 16, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Mar 8, 2023 Mar 8, 2023
10-K Annual report Mar 8, 2023 Dec 31, 2022
8-K Current report
Officer or director change
Jan 5, 2023 Jan 3, 2023
424B3 Prospectus Nov 17, 2022 —
EFFECT Filing Nov 16, 2022 —
CORRESP Letter to the SEC Nov 14, 2022 —
UPLOAD Letter from the SEC Nov 9, 2022 —
S-3 Shelf registration Nov 3, 2022 —
10-Q Quarterly report Nov 2, 2022 Sep 30, 2022
8-K Current report
Results of operations, Regulation FD disclosure
Nov 2, 2022 Nov 2, 2022
D Filing Oct 14, 2022 —
424B5 Prospectus supplement Oct 11, 2022 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 11, 2022 Oct 10, 2022
8-K Current report
Material agreement, Agreement ended
Oct 3, 2022 Sep 30, 2022
CT ORDER Filing Sep 7, 2022 —
10-Q Quarterly report Aug 10, 2022 Jun 30, 2022
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Aug 10, 2022 Aug 8, 2022
8-K Current report
Shareholder vote results, Other events
Jun 21, 2022 Jun 16, 2022
8-K Current report
Officer or director change
Jun 9, 2022 Jun 3, 2022
8-K Current report
Material agreement, Regulation FD disclosure
May 19, 2022 May 19, 2022
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2022 May 12, 2022
10-Q Quarterly report May 12, 2022 Mar 31, 2022
DEFA14A Additional proxy material Apr 27, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 16, 2022
8-K Current report
Officer or director change
Apr 18, 2022 Apr 14, 2022
8-K Current report
Officer or director change
Apr 15, 2022 Apr 11, 2022
8-K Current report
Officer or director change
Apr 11, 2022 Apr 5, 2022
8-K Current report
Officer or director change
Apr 8, 2022 Apr 4, 2022
8-K Current report
Regulation FD disclosure
Mar 23, 2022 Mar 23, 2022
10-K Annual report Mar 14, 2022 Dec 31, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Mar 9, 2022 Mar 9, 2022
8-K Current report
Material agreement, New debt
Dec 15, 2021 Dec 11, 2021
8-K Current report
Officer or director change
Dec 13, 2021 Dec 13, 2021
8-K Current report
Officer or director change
Dec 1, 2021 Dec 1, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Nov 3, 2021 Nov 3, 2021
10-Q Quarterly report Nov 3, 2021 Sep 30, 2021
8-K Current report
Officer or director change
Oct 29, 2021 Oct 19, 2021
8-K Current report
Other events
Sep 30, 2021 Sep 27, 2021
8-K Current report
Other events
Sep 15, 2021 Sep 14, 2021
10-Q Quarterly report Aug 3, 2021 Jun 30, 2021
8-K Current report
Results of operations, Regulation FD disclosure
Aug 3, 2021 Aug 3, 2021
8-K Current report
Shareholder vote results
Jun 22, 2021 Jun 17, 2021
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2021 May 6, 2021
10-Q Quarterly report May 6, 2021 Mar 31, 2021
EFFECT Filing Apr 22, 2021 —
424B3 Prospectus Apr 22, 2021 —
CORRESP Letter to the SEC Apr 21, 2021 —
DEFA14A Additional proxy material Apr 21, 2021 —
DEF 14A Proxy statement Apr 21, 2021 Jun 17, 2021
UPLOAD Letter from the SEC Mar 25, 2021 —
S-3 Shelf registration Mar 23, 2021 —
10-K Annual report Mar 12, 2021 Dec 31, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Mar 10, 2021 Mar 10, 2021
D Filing Mar 3, 2021 —
8-K Current report
Unregistered share sale
Feb 25, 2021 Feb 23, 2021
8-K Current report
Material agreement
Feb 22, 2021 Feb 20, 2021
8-K Current report
Regulation FD disclosure
Dec 9, 2020 Dec 9, 2020
8-K Current report
Other events
Nov 23, 2020 Nov 17, 2020
10-Q Quarterly report Nov 4, 2020 Sep 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2020 Nov 4, 2020
CT ORDER Filing Oct 28, 2020 —
CT ORDER Filing Sep 11, 2020 —
S-8 Employee stock plan registration Aug 18, 2020 —
CT ORDER Filing Aug 17, 2020 —
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Aug 6, 2020 Aug 6, 2020
8-K Current report
Other events
Jul 8, 2020 Jul 6, 2020
EFFECT Filing Jun 26, 2020 —
424B5 Prospectus supplement Jun 26, 2020 —
CORRESP Letter to the SEC Jun 24, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 22, 2020 Jun 19, 2020
UPLOAD Letter from the SEC Jun 18, 2020 —
S-3 Shelf registration Jun 12, 2020 —
424B3 Prospectus Jun 3, 2020 —
EFFECT Filing Jun 1, 2020 —
8-K Current report
Regulation FD disclosure
May 29, 2020 May 29, 2020
UPLOAD Letter from the SEC May 28, 2020 —
CORRESP Letter to the SEC May 28, 2020 —
CT ORDER Filing May 26, 2020 —
S-3 Shelf registration May 21, 2020 —
D Filing May 20, 2020 —
10-K/A Amended annual report May 18, 2020 Dec 31, 2019
10-Q Quarterly report May 18, 2020 Mar 31, 2020
NT 10-Q Nt 10q May 12, 2020 Mar 31, 2020
8-K Current report
Results of operations, Regulation FD disclosure
May 11, 2020 May 11, 2020
8-K Current report
Unregistered share sale
May 7, 2020 May 7, 2020
8-K Current report
Material agreement
Apr 29, 2020 Apr 27, 2020
DEFA14A Additional proxy material Apr 21, 2020 —
DEF 14A Proxy statement Apr 21, 2020 Jun 19, 2020
CT ORDER Filing Apr 2, 2020 —
CT ORDER Filing Mar 24, 2020 —
CT ORDER Filing Mar 24, 2020 —
CT ORDER Filing Mar 19, 2020 —
8-K Current report
Results of operations, Regulation FD disclosure
Mar 10, 2020 Mar 10, 2020
10-K Annual report Mar 10, 2020 Dec 31, 2019
8-K Current report
Officer or director change
Jan 10, 2020 Jan 7, 2020
8-K Current report
Results of operations, Regulation FD disclosure
Nov 12, 2019 Nov 12, 2019
8-K Current report
Material agreement, New debt
Nov 12, 2019 Nov 12, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
CT ORDER Filing Oct 24, 2019 —
CT ORDER Filing Oct 24, 2019 —
8-K Current report
Other events
Oct 11, 2019 Oct 9, 2019
EFFECT Filing Oct 2, 2019 —
424B3 Prospectus Oct 2, 2019 —
CORRESP Letter to the SEC Sep 30, 2019 —
CORRESP Letter to the SEC Sep 26, 2019 —
S-3/A Amendment no. 1 to s-3 Sep 26, 2019 —
UPLOAD Letter from the SEC Sep 20, 2019 —
S-3 Shelf registration Sep 12, 2019 —
D Filing Aug 29, 2019 —
8-K Current report
Material agreement, Unregistered share sale
Aug 15, 2019 Aug 15, 2019
8-K Current report
Material agreement
Aug 14, 2019 Aug 13, 2019
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2019 Aug 7, 2019
10-Q Quarterly report Aug 7, 2019 Jun 30, 2019
8-K Current report
Material agreement
Jul 1, 2019 Jun 30, 2019
8-K Current report
Shareholder vote results
Jun 27, 2019 Jun 21, 2019
CT ORDER Filing Jun 4, 2019 —
D Filing May 24, 2019 —
8-K Current report
Unregistered share sale
May 20, 2019 May 17, 2019
8-K/A Amended current report
Material agreement
May 14, 2019 Dec 19, 2018
8-K Current report
Material agreement
May 10, 2019 May 9, 2019
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2019 May 9, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
DEFA14A Additional proxy material Apr 23, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
NAGE (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Los Angeles, CA
SEC filer status
Large accelerated filer
SEC CIK
1386570
Former names
ChromaDex Corp. (until Mar 10, 2025); CODY RESOURCES, INC. (until Jun 24, 2008)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.